Turkey has entered a technical recession, with the economy contracting by 0.2% quarter-on-quarter in the third quarter. This marks the second consecutive decline, driven by high interest rates that have hindered industrial production and investment in the $1.3 trillion economy.
UBS has increased its target price for the London Stock Exchange from 10,100 to 11,500 pence while maintaining a "Neutral" rating. Analyst Michael Werner noted that the strong US dollar is boosting the exchange operator's profits, prompting a shift in the valuation basis in his cash flow model.
08:03 29.11.2024
The Sensex surged 721.31 points to 79,765.05, while the Nifty rose 208.50 points to 24,122.70, driven by gains in auto, pharma, energy, and infrastructure stocks. However, PSU banks faced declines amid perplexing volatility in foreign institutional investor activity, with a significant sell-off of Rs 11,756 crores noted recently. Investors are advised to remain cautious as stock-specific actions are anticipated following the inclusion of 45 new stocks in the F&O list.
The Canton of Bern, Switzerland, has passed a bill with 85 votes in favor to study the impact of Bitcoin mining, aiming to utilize surplus energy and support renewable energy initiatives. Inspired by Texas, the legislation seeks to attract mining companies, create jobs, and stabilize the electricity grid. Despite opposition from the Government Council, the proposal reflects Switzerland's growing interest in Bitcoin mining, particularly as Bern is a net energy exporter.
08:00 29.11.2024
The assets of Switzerland's wealthiest individuals have surged to a record 833.5 billion Swiss francs, marking a 4.8% increase after two years of decline. Gérard Wertheimer leads the list with an estimated fortune of 37 to 38 billion francs, despite a decrease in his wealth. Notable newcomers include crypto investors Giancarlo Devasini and Christian Angermayer, reflecting the growing influence of digital assets among the super-rich.
GERRESHEIMER AG, a German company, operates in the pharmaceutical and healthcare sectors through two main segments: Plastics and Devices, and Primary Packaging Glass. The Plastics and Devices segment produces drug delivery products like insulin pens and inhalers, while the Primary Packaging Glass segment manufactures glass packaging for pharmaceuticals, cosmetics, and food and beverages. With around 40 production facilities across Europe, North America, South America, and Asia, the company is well-positioned in its industry.
07:51 29.11.2024
UBS has maintained a 'Buy' rating for Gerresheimer, setting a target price of 132 euros. Analyst Olivier Calvet noted that data from Novo Nordisk's weight-lowering drug CagriSema could positively impact Gerresheimer, positioning it favorably compared to Ypsomed. Schott Pharma and Stevanto remain unaffected.
07:51 29.11.2024
Hungarian Prime Minister Viktor Orban has nominated his finance minister, Mihaly Varga, to lead the National Bank of Hungary starting in March, following the end of Governor Gyorgy Matolcsy’s term. Orban is also expected to consolidate economic policy under a "superministry" by appointing Marton Nagy as finance minister, although this has not been officially confirmed.
UBS has maintained a neutral recommendation for London Stock Exchange Group Plc, a leading European stock exchange. The company's revenue sources include stock market information and analytical data (69.9%), trading services (19.2%), and post-trading services (10.9%). Geographically, revenues are derived from the United Kingdom (30.9%), Europe (14.9%), the United States (36.6%), Asia (12.3%), and other regions (5.3%).
07:50 29.11.2024
The wireless healthcare market is projected to grow from $174.27 billion in 2023 to $205.78 billion in 2024, driven by the demand for remote access via mobile phones and innovations in wearable health devices. By 2028, the market is expected to reach $422.16 billion, fueled by global health responses and advancements in digital therapeutics. Key players include AT&T, Cerner, and Qualcomm, among others, highlighting a competitive landscape focused on enhancing healthcare delivery through technology.

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings